© Copyright 2007 Deborah Mowshowitz and Lawrence Chasin Department of Biological Sciences Columbia University New York, NY.  Last Update 11/25/2007 12:09 PM

Handouts: You need 21A (Crosses -- not on web) & 21B (for dominance & pedigrees).

Note: There are many examples of genetic conditions described here. The basic principles, but not all the details, will be covered in class. Be sure you understand all the examples -- ask your TA or email Dr. M if you have any questions.

I. Inactive X's and Barr bodies -- Why extra or missing X's are usually tolerated and extra or missing autosomes are not. (This = topic VI of last lecture.)

     The idea that extra X's are genetically inert is called the Lyon hypothesis (or the inactive X hypothesis). According to the Lyon hypothesis, every female is a mosaic, since some of her cells use her maternal X to make proteins and some use her paternal X.

II. Patterns of Inheritance -- An example and the general principles -- See Top half of Handout 21A

    A. What are the Big Issues to consider?

         1.  How are genes/genotypes inherited, and

        2.  How does a particular genotype (state of the genetic information) determine phenotype (appearance, function, etc)?

    We'll start by looking more closely at the example of orange/black coat color in cats and then go on to other examples and the general case.

    B. How do you figure out the pattern of Inheritance? -- an example for a gene on the X For a different classic example of inheritance of a sex-linked trait, see Sadava 10.23. (For this, and many of the other figures in this lecture, the fig. or table # is the same in the 7th & 8th editions of Purves/Sadava.)

Note: The term "trait" is used in several different ways. It usually means whatever property you are following. Depending on the circumstances, it can mean the overall property you are considering such as coat color, OR it can mean the form (phenotype) of that property that you are following, such as orange coat color. So people speak of "the fur color trait" or "the orange color trait" depending on the context. ("Trait" is also sometimes used to refer to the carrier or heterozygous condition, as in "she has the sickle cell trait" meaning she has no symptoms but carries one allele for sickle cell.)

Consider a gene on the X such as the one that determines orange vs black coat color. Suppose you mate a tortoiseshell female cat X orange male (see handout 21A). How do you figure out what will happen?  Follow the steps below. (Each step is drawn on handout for each parent.)

        1. Draw parental chromosomes with proper alleles.

            a. Number of gene copies. For genes on the X: Male has only one copy (allele) of the gene, female has two copies (alleles). For a genes on an autosome (discussed below), both male and female have two alleles of each gene.

            b. Terminology (for an individual with two alleles).  If both alleles are the same, individual is said to be homozygous or a homozygote. In this case, a homozygous cat can be either homozygous black or homozygous orange. If the two alleles are different, the individual is said to be heterozygous or to be a heterozygote. A tortoiseshell cat must be heterozygous.

        2. Go through DNA replication to double DNA, chromatids/chromosome and # alleles/cell. Note sister chromatids are identical (if no crossing over**) but homologs need not be. 

            a. Sister chromatids must be identical since they are the 2 products of a single, semi-conservative, DNA replication. (See ** below.)

            b. Homologs need not be identical -- one came from the mother and one the father.  Homologs DO need to have the same genes (loci) lined up in the same order -- they just don't have to have the same alleles of these genes. In this case, for the heterozygous female cat, one homolog has the orange allele of the coat color gene (at the coat color locus), and the other homolog has the black allele of the coat color gene. 

        3. Go through meiosis: Homologs separate at first division and sister chromatids separate at second division. This produces 4 gametes -- two different kinds, but in equal proportions (again assuming no crossing over**). 

**Note: Crossing over does not make any significant difference here because you are following only one gene at a time. When you start considering two or more genes at a time, then you have to take crossing over into account, and we'll explain how to do that later. We're ignoring it now, because the gametes come out the same (for the one gene under consideration) whether there is crossing over or not. See Becker fig 20-14 [18-14] or Sadava 10.19. Crossing over occurs in both figures, but you still get two gametes with one allele of the gene (Y in Becker or B in Sadava) and two gametes with the other allele (y or b). 

        4. Do fusion of gametes from both parents to get zygotes (cats). You can use a Punnett square (or simple probability) to keep track of all combinations and proportions. This gives you the genotypes of the offspring (zygotes). 

        5. Look at genotypes and infer phenotypes of offspring = what develops from zygotes. Consider all possible combos and what proportions they occur in. Note that in this case there is no dominance, so phenotype follows directly from genotype. If cat has only black (or only orange) alleles, you get a black (or orange) cat. If cat has both alleles, you get a tortoiseshell cat. Cat is black in areas where X with B allele is on active X; cat is orange in areas where X with O allele is on active X. (See below for mechanism of determination of black vs. orange.)

        6. Terminology (for genes on the X): In this course, and in many other contexts, the terms 'sex-linked' and 'X-linked' are used interchangeably, so sex linked = 'on the X chromosome.' If a gene is on the Y chromosome, a different term is used. Some biologists use the term 'sex-linked' to refer to genes on either the X or the Y. However, since there are very few genes on the Y, genes referred to as 'sex-linked' are almost always on the X (no matter how the term 'sex-linked' is used).

    C. How does genotype determine phenotype?

How does a gene specify orange or black?  In all cases, to figure out how genotype and phenotype correspond, you need to consider the enzymes and pathways involved. Current understanding of this case is as follows:

        1. Black Part -- how is black pigment made?

Gene A is probably on an autosome.    

     2. Orange part -- how is orange pigment made?

A gene on the X (call it gene C) codes for an enzyme that converts the black stuff into orange stuff. (The difference in color is probably caused by a different arrangement of pigment granules.) This gene has two alleles, called "O" and "B" above.

        3. What determines orange vs black?

What differs between orange and black cats is the activity of the second enzyme. If the second enzyme is active, the black pigment is converted to orange. If the second enzyme is inactive, the black pigment remains black.

How the alleles of gene C determine color:

• The O allele → working peptide → catalyzes conversion of black stuff into orange.
   
• The B allele → no working peptide → no conversion of black stuff into orange so black color shows up (black not masked).

        4. General Case.

• We will see many cases like this where one allele → working peptide and other allele does not.
   
• This is not always the case -- sometimes one allele → working peptide and other allele gives an altered, but working, peptide, as in HbA vs HbS or bloodtypes A and B.
   
• What happens to phenotype (in a heterozygote) usually depends on job of peptide, and whether gene is on X or autosome. See handout 21B and below for examples.

For a sample problem on sex linked inheritance, try problem 9-9 A & C. (Part B depends on a discussion of dominance, which will be considered later.)

III . How does inheritance work for autosomal genes? See bottom half of Handout 21A.

    A. Blue (bl) vs Brown (br) eye color -- an example (For a different classic example of inheritance of an autosomal trait see Sadava figs. 10.3 & 10.4 (for bkg info see previous figs. & table 10.1) or Becker fig. 20-11 & 20-12 [18-11 & 18-12].)

       1. Crosses to consider: Suppose you start with homozygous bl X homozygous br (= parental generation) to get heterozygous offspring (first filial generation or F₁); then you cross two heterozygous F₁'s to get the next  (F₂) generation.

        2. Genotypes of gametes and zygotes  -- genotypes are determined as shown on handout, and the steps are the same as in the case above (steps 1-4). However the  types of gametes, genotypes of zygotes, and their proportions, are different, because coat color gene is on X chromosome and eye color gene is on an autosome. Important difference: for autosomal genes, the gametes produced by a heterozygous male or female are identical.  

        3. Phenotypes (step 5)  -- phenotypes depend on the roles of the products of the bl and br alleles. There is no inactivation of autosomes, so you  need to figure out what phenotype of heterozygote will be. What will it look like? The usual answer is, "it will be brown, because brown is dominant." But why is br dominant to bl? What is the underlying mechanism?

            a. You need to consider what the two alleles do.

• br allele → enzyme; catalyzes conversion of colorless stuff → brown
   
• bl allele → no active enzyme; no brown stuff made. Eye appears blue (due to light scattering) in absence of brown pigment.

            b. So what happens in heterozygote (when both alleles are present)? What will it look like?

• br allele → enzyme → brown pigment.
   
• Presence of bl allele has no effect on action of br allele or its products. Therefore eyes of heterozygote are brown.

            c.  This situation (dominance of allele coding for active enzyme) is common -- Usual Features

• Enzyme is produced constitutively; number of copies of gene determine amount of mRNA and protein made.
   
• One allele → active enzyme → job done; other allele → no (active) enzyme; without active enzyme job doesn't get done.
   
• In heterozygote, one allele → active enzyme; other allele → no enzyme. Total amount of enzyme is 1/2 the amount in a normal (homozygote), but it is enough to get the job done.  Therefore, effects of allele that produces enzyme override effects of allele that → no enzyme.
   
• Note it is the products of the alleles (the enzymes, proteins, etc.) that determine what will happen in a heterozygote, not the alleles themselves. In this case, the normal allele is dominant to the allele that makes no product. This is the usual case, but there are exceptions. Other possibilities are discussed below.

        4. Dominance -- terminology and symbols.

• Whenever effects of one allele (really the products of the allele) override effects of another allele, the first allele is said to be dominant and the second allele is said to be recessive.
   
• In this case br is dominant and bl is recessive. In that case, the symbols B and b (upper and lower case of same letter) are often used for the pair of alleles. Use of two forms of the same letter emphasizes we are dealing with two forms (alleles) of the same gene, not different genes.
   
• Whether you use B & b or bl & br, it is usually wise to use one set of symbols for the phenotypes (blue and brown) and a DIFFERENT set of symbols for the alleles (bl and br or B and b.) Using the same terms (blue & brown) for alleles/genotypes and traits/phenotypes can cause lots of unnecessary confusion.

         5. Summary of results for parents → F1 → F2

For a review of the terminology and a sample cross with an autosomal gene, try problem 9-1. For more practice, try 9-3 & 9-4.

Note that Becker and Sadava both have genetics problems at the end of the respective chapters. (Answers to problems in Sadava are in the back of the book. Answers to problems in Becker are in the Solutions Manual, which should be on reserve in the Biology Library, 601 Fairchild.)

    B. General Case   --  see bottom of 21A for genotypes; see below and bottom of 21B for phenotypes)

        1. Alleles:

• Assume A = normal allele.
• A* = mutant or altered allele.

        2. Crosses -- Genotypes

a. P X P →F1 

    Parents = AA X A*A*

    What are gametes from each parent?    

    Mix gametes to get zygotes; Get all heterozygotes in first generation of offspring (F₁)

 b. When cross two F1's  → F2

    Parents = AA* X AA*

    What are gametes from each parent?    

    Mix gametes to get zygotes. Not all zygotes are the same. You get:

        1:2:1 genotype  = AA:2AA*:A*A*  in second generation of offspring (F₂)

          2. Phenotypes. Remember there is no inactivation for autosomal genes. So # of phenotypes and their proportions depend on the answer to the question: what will AA* look like?

• Assume A → normal enzyme or peptide
• A* → altered peptide or none.

Phenotype of AA* depends on how altered the product of A* is, whether it interferes with action of normal enzyme, etc. AA* can look like AA, A*A* or in between. A* can be dominant to A, or A and A* can be co-dominant, or either allele can be only partially dominant over the other. It all depends on what the job of gene A is and how different the product of allele A* is from the product of allele A. See next section for details.

IV. Details of Phenotypes -- Dominance Relationships

  A. A* is recessive -- Bl vs Br or PKU

           1. Mechanism.   In these cases, lack of an enzyme usually causes a block in metabolism. The resulting symptoms (for a disease) can be due to the build up of intermediates and/or to the lack of end product.  The individual is normal as long as there is at least one A (normal) allele that → some working enzyme. So AA and AA* or A_ genotypes have normal phenotypes (they look and act the same). But A*A* individuals have no enzyme; they have a block in metabolism and have the disease. 

            2. Examples:

•  Phenylketonuria (PKU) -- can't break down the amino acid phenylalanine → tyrosine. See Sadava fig. 17.1.
•  Galactosemia -- can't break down and get energy from galactose
•  Tay-Sachs disease (TS) -- can't break down a complex lipid in nerve cells
•  Cystic fibrosis (CF) -- can't transport ions properly in and out of cells. See Sadava fig.17.3 (b).

          3. Treatment by alteration of diet. In some cases, manipulating the diet gets around the block and prevents symptoms. Examples: 

            a. PKU -- Block is in conversion of the amino acid phenylalanine (phe) to tyrosine. You need to provide just enough phe so person can make proteins and grow, but you need to keep phe levels low so none is left over, since excess can not be broken down and disposed of. Excess phe (or compounds derived from it) interfere with brain development and cause severe mental retardation. The altered diet is extremely successful -- average IQ of untreated person (on normal diet) is 53; average IQ of treated person is 93. All newborns in the US are screened for this condition. See Sadava  fig. 17.11 (17.10).

            b. Galactosemia -- block is in conversion of galactose to glucose. Need to eat a diet without galactose (that means without milk, since the sugar in milk is lactose, a disaccharide of glu and gal). Provide glucose instead as an energy source.

        4. Protein or Gene replacement

            a. Why can't you just add the missing protein? The protein usually gets broken down before it reaches its target cells. This is what usually happens; only a few proteins (mostly those that function in blood such as insulin and clotting factors) can be supplied from outside.

            b. Why Gene therapy. It should be easier to target intact genes to the right cells than it is to target intact proteins. Also, once the genes reach the correct cells, they should continue to make proteins for a long time, perhaps for the life of the person. Everyone assumes this will work eventually, but so far, gene therapy has not been very helpful, and there have been some recent serious problems.  See Sadava 17.21 (17.20) for outline of the procedure. 

        5. In some cases you can't do anything to avoid the block in metabolism (except prevention -- see below). Protein (or gene) replacement isn't feasible, and changing diet doesn't help. Examples:  

            a. TS (Tay Sachs Disease). Lipid is made irrespective of diet -- it is continually made and broken down ("turned over") in nerve cells of normal people; in people with TS the lipid is made but can't be removed so it just piles up until it destroys the nerve cells and causes death, usually by age 5.

            b. CF (cystic fibrosis) -- Defect is in protein needed for ion transport in and out of cells. Protein is not made or is not transported to the right place in the cell. You can't get around actual defect but can relieve symptoms (accumulation of mucus in lungs, etc.) and extend length and quality of life; gene therapy is in the works. Eventually added genes should produce protein that is targeted correctly to the right part of the cell, and allow normal ion transport.

For a problem involving a typical recessive autosomal disease see 9-8. For a problem on genetic testing see 9-13.

    B. A* is dominant -- for example, HD (Huntington's Disease)

        1. Mechanisms are various. Either

            a. Not enough (normal) protein. 1/2 usual amount of protein isn't enough; protein can be catalytic and not shovel fast enough or structural and not hold up the roof.  Example: HC.   

            b. Presence of abnormal protein. Abnormal protein can cause problems directly;  functioning of abnormal protein can interfere with normal. Example: HD.

        2. Examples of dominant diseases: 

            a. Hypercholesteremia (HC). HC is due to a defect in the carrier (receptor) for uptake of cholesterol from the blood. Heterozygotes have half the usual carrier level, and half the rate of uptake. Blood cholesterol gets too high, causing  premature heart attacks. See Sadava 17.3A (17.3a). Homozygotes (who are quite rare) have no receptor and have even higher levels of blood cholesterol; they have  heart attacks at extremely early ages. This disease (or the mutant allele that causes the disease) is considered dominant, although it is really partially dominant -- homozygotes have less function and more severe symptoms than heterozygotes.

            b. Huntington's Disease (HD). A defective protein gums up the brain causing degeneration of nerve function. Symptoms do not occur until late in life, usually well after reproductive age. In this case, the altered protein encoded by the mutant allele appears to interfere with the functioning protein made by the normal allele. This disease is completely dominant -- homozygotes and heterozygotes have similar symptoms.

        3. Treatment: 

            a. HC. Diet and cholesterol-lowering drugs (statins) are the standard treatment. The drugs inhibit enzymes of cholesterol synthesis. If gene therapy is tried, it will probably not involve adding a normal copy of the defective gene, as one normal copy is already present (in heterozygotes). Instead, the genetic engineering methods will attempt to change regulation (increase gene expression = up-regulate)  the normal allele which is already there. 

            b. HD. No treatment currently exists. Prevention is the only option. Therapeutic abortion is problematic here, as affected individuals can be asymptomatic for 40-50 years before they develop the disease. If gene therapy is tried here, it will involve attempts to silence (down-regulate) the abnormal allele, possibly by anti-sense technology (adding RNA complementary to mRNA or the equivalent RNAi technique). The issue here is to decrease gene expression. Pre-symptomatic diagnosis is possible -- you can determine from DNA tests if a person (who is still healthy) carries the defective allele and will develop HD eventually. For a discussion of the issues involved here, both biological and otherwise, see Mapping Fate by Alice Wexler. (She is from a family with the condition.)

For a problem on inheritance of a dominant condition, see 9-12. For a review of the relationship between dominance and enzyme function, see 9-18.

    C. Incomplete or partial dominance. Example -- red vs white vs pink flower color.

In cases above, AA* looked like one parent. What if the heterozygote looks or acts in between? For example, in some plants, crosses between red-flowered plants and white-flowered homozygous plants → F₁ offspring with pink flowers. This is usually called incomplete or partial dominance. In this case, the flower color gene codes for an enzyme that catalyzes pigment production. An AA* plant makes 1/2 of the enzyme found in an AA; this catalyzes production of 1/2 the amount of red pigment found in an AA. The red pigment is spread more thinly giving a pink appearance. See Sadava fig. 10.12 (10.13). Incomplete dominance occurs because the amount of enzyme is limiting in pigment production. (Incomplete and partial dominance are synonymous; they are similar to, but not exactly the same as, co-dominance, the next case.)

Look at problem 9-7. One of the cases here (you figure out whether it's A or B) is an example of incomplete dominance.

     D. Co-dominance.  

        1. Idea: In all cases so far, one allele → inactive or defective product. What if each allele produces a working product, but the products are different? Then each allele/product  will "do its thing" unaffected by the other. 

        2. Example #1 -- MN blood type:  This is controlled by one gene with two co-dominant alleles. Each allele codes for a slightly different version of the same cell surface protein. (The protein is not an enzyme; its normal function is unknown.)

        3. Example #2 -- ABO blood type. This is controlled by one gene with 3 alleles; 2 of the alleles are co-dominant. See Sadava 10.13 (10.14).

    a. Role of gene product: The gene codes for an enzyme that adds sugars to the surfaces of red blood cells (RBC's).

    b. Role of Different Alleles The 3 alleles of the gene code for variant forms of the same enzyme.

    c. Dominance Relationships: Two of the alleles (I^A and I^B) are co-dominant to each other and both are dominant over the third allele (i).

    d. Mechanism

      (1)  The two co-dominant alleles  -- code for variant (working) forms of the same enzyme. The substrate binding sites of the two forms are slightly different. Therefore the two different forms of the enzyme bind slightly different sugars, and add different sugars to the surfaces of red blood cells (RBC's).

            (a). I^B -- One working form of the enzyme, coded for by the I^B allele, adds the sugar galactose to the surface of RBC's.  RBC with galactose  → B blood type. (In picture below, G on cell surface = galactose.)

            (b). I^A  -- The other working type of enzyme, coded for by the I^A allele, adds the modified sugar acetyl galactosamine. RBC with galactosamine  → A blood type. (In picture below, A on cell surface = acetyl galactosamine.)

        (2)  The i allele -- codes for an inactive (non working) enzyme; cells with ii genotype → no enzyme → no sugars added. If no sugars → O blood type.

    e. Heterozygotes: How genotype & phenotype match up.

        (1). Type AB: I^AI^B individuals have a mixture of both enzymes and a mixture of sugars on their RBC → AB blood type.

        (2). Type A & B: Both homozygous I^A and heterozygous I^Ai have only one type of enzyme and acetyl galactosamine on their RBC's and are type A; similarly both I^BI^B and I^Bi have galactose and are type B.

    f. Multiple alleles: This gene has 3 different alleles. Any gene can have many alleles because many different variants of the same DNA sequence are possible. Often the alleles divide into two classes, those → functional enzyme and those → nonfunctional enzyme. In this case, two of the alleles → two slightly different but functional enzymes. For another example of multiple alleles, see Sadava 10.11 (10.12).

 For role of ABO in transfusions, see Sadava 10.13 (10.14).

See problem 9-2 for a simple case of co-dominant inheritance. See 9-5 for a review of the genetics of the ABO blood type.


V.  Dominance & Genetic Conditions -- some additional features to consider

  A. Dominance/recessiveness for sex linked conditions.   How can mutations on the X chromosome be recessive? 

    You would think mutations on the X would show up in a heterozygous female because of the inactive X, just as black color shows up in a heterozygous O/B cat. Since only one X chromosome works per cell, a heterozygous female should be a mosaic. Some cells should use the X with the mutant allele and have a mutant phenotype; some cells should use the normal X and have a normal phenotype. This is what occurs, so there is no dominance on the cell level in a female,  But what about the whole organism? If half the cells have a normal phenotype, the organism as a whole may have a normal phenotype. Therefore, even with the inactive X, you can have dominance on an organismic level for genes on the X.

    Example: hemophilia. Hemophilia is caused by a lack of a clotting factor encoded by a gene on the X chromosome. Gene has alleles H and h. (H = good allele; h = inactive allele) In a heterozygous Hh female, only one X chromosome works per cell, so woman is mosaic -- the H allele is used in some cells and the h allele in the others. Therefore 1/2 her cells will make good clotting factor and half will make none. However the clotting factor is secreted into the blood, so her blood will contain clotting factor. Even though some cells make clotting protein and some don't, her blood overall will contain enough clotting protein so there'll be no problem. (Remember the usual case is that 1/2 of the usual amount of enzyme is enough; the clotting factor is an enzyme.)

    Another example: colorblindness. A female heterozygous for color blindness, also on the X, has normal vision since aprox. every other cell has good light receptors. In this case, the mosaic is so finely grained it isn't noticeable. See Sadava 10.24.

To review issues of dominance of X-linked traits, look at 9-9B and 9-14.

    B. Disease vs variation: Some of the examples above involve "normal variation" -- blue vs brown, AB vs O etc. Neither blue nor brown is considered  "abnormal" or "mutant." Some examples involve  genetic diseases, where one phenotype is clearly "abnormal" and the other is not. In some cases, it is not clear cut what is "normal" and what is not. 

    C. Inherited Diseases  -- how to define a disease as dominant or recessive.  Terminology for genetic diseases 

        1. Dominant conditions: If one A* causes disease  =  effects of A* show up even in presence of A = A*_ is sick (whatever allele is in the blank), then you call A* and/or the disease it causes dominant. It doesn't matter if if two A** alleles are worse than one, and A*A* is sicker than A* A --  as long as both homozygotes and heterozygotes have symptoms, the disease is considered dominant, although strictly speaking it should be considered partially dominant.

        2. Recessive conditions: If it takes two A* alleles to cause disease, so only homozygotes (A*A*) are affected, allele and/or disease it causes are called recessive. 

        3. How is this terminology different than usual?  In many cases, A* is considered dominant if AA* and A*A* have the same phenotype. A is considered dominant if AA* and AA have the same phenotype. If AA* has an "in between" phenotype, then neither allele is considered to be dominant or A* is said to be partially dominant. For genetic diseases, A* is usually considered dominant if AA* has symptoms, even if they are not as severe as for A*A* (as for hypercholesterolemia.)

VI. Summary of Options for Treatment, Diagnosis & Prevention of Genetic Diseases

    A. Alteration of Diet  --  in some cases altering the diet can avoid the consequences of genetic blocks. Details above for PKU, galactosemia.

    B. Drugs -- in some cases drugs can alter enzyme production or activity and circumvent (or alleviate) consequences of genetic blocks. (Details above for Hypercholesterolemia ). Drugs are often more effective when combined with an alteration of diet.

    C. Protein or Gene replacement -- Protein replacement works in a few cases, and gene therapy is under development; see above.

    D. Prevention -- what can you do if there is no treatment?

            a. Why carrier testing? (For recessive conditions.)

    A*A* or aa individuals come primarily from marriages of two heterozygotes (affected individuals don't usually marry and reproduce). If one parent is AA and one is Aa, child can not inherit the disease since child cannot inherit two a's. In other words, a couple (with normal pheno) is at risk of having an affected child only if both parents are Aa. If potential parents are tested, and are both Aa, they can avoid having an aa child by various procedures -- adoption, artificial insemination, egg donation, etc. Or they can do prenatal testing as follows.

             b. How do you do Carrier Testing for recessive conditions?

    How can you detect carriers if their phenotype is normal? Carriers or heterozygotes usually produce about 1/2 as much enzyme as homozygous normal. This occurs because transcription of structural genes is often not regulated; all copies of the gene are expressed (transcribed) constitutively. AA individuals have two copies of the gene, so they make two units of mRNA and a corresponding amount of protein (100%). AA* (Aa) heterozygotes have only one copy of the (working) gene so they make one unit of (working) mRNA and 1/2 as much protein (50%). As long as some enzyme is present, there is no block in metabolism and the "job gets done." That is why Aa and AA have the same gross phenotype. But their enzyme levels are different, and this allow testing and detection of carriers. (DNA tests can also detect many carrier states.)

            c. Amniocentesis, prenatal testing & therapeutic abortion

    Cells of fetus can be harvested by amniocentesis (sampling of fluid surrounding the fetus). Fetal cells can be tested for DNA and/or enzyme levels and for chromosomal abnormalities. If mutation causing a disease is known, DNA can be tested directly. For recessive conditions, enzyme levels in fetal cells can be tested; in an aa fetus, enzyme level will be zero. (DNA must be tested if cells in amniotic fluid do not express the enzyme/gene.)  If parents wish to do so, an affected fetus can be aborted. Whether a therapeutic abortion is appropriate or not is an ethical question to which there is no simple answer; the question is more difficult when the outcome of the disease is uncertain, or symptoms normally develop only at an advanced age (as for Huntington's). 

VII. Pedigrees and Ratios -- How do you follow the pattern of inheritance?

    A. Ratios: How do you tell if a condition is dominant or recessive? 

       For experimental plants and animals, you start with parents of known genotype, say a homozygous normal X homozygous affected, and cross them to get descendants (first an F₁ and then an  F₂ generation). Each case should produce characteristic ratios of phenotypes (normal: in between: mutant) in the F₂. (See handout 21B, bottom.) 

        1. If gene is autosomal, in F₂ expect 3:0:1 (known as 3:1), or 1:0:3 (known as 1:3) or 1:2:1 ratios in phenotypes. Note that dominance relationships depend on structure and function of gene product, not gene itself. 

Problem 9-7 is an example of the use of ratios.

        2. If a gene is sex-linked (on the X), the ratios of normal to affected will be different than those given above, and (at least in some cases) ratios will be different depending on which parent (normal or affected) is the female and which is the male. See Sadava 10.23 & intro to chapter 10.   

For inheritance of X-linked traits (using ratios), see Problem 9-10.

    B. Pedigrees -- How do you tell if a new human condition is dominant or recessive?

The obvious thing is to do the crosses as above and look at the ratios of phenotypes. But you can't cross people! So you look at pedigrees = crosses already done for you. 

    1. Example of a pedigree = top example on handout 21B.  See also Sadava 10.10 (10.10 && 10.11) & 10.24.  

Note: affected means "has whatever condition we are talking about." It is not the same as infected, which means "has been invaded by an infectious organism," such as a bacterium or a virus. 

        2. General procedure for analyzing pedigrees:

           a. Use trial and error! You make a guess -- say, let's assume condition is autosomal and dominant. Then you try to assign each individual in the pedigree a genotype consistent with this assumption. If it works, that means condition could be autosomal dominant. If it doesn't work, you've ruled out autosomal dominant. You try to narrow down the possibilities as much as possible.

            b. Don't Use Proportions: In most pedigrees the proportions of affected : normal in each marriage are not significant because the sample sizes are too small. If a Aa marries an aa and has a few kids, you don't expect to get an exact 1:1 ratio of Aa: aa in the offspring. Proportions are only useful in very large pedigrees or families with many descendants. What matters in most pedigrees is whether the pedigree is possible -- could these parents have these kids and vice versa? You test for what is possible or not, not whether proportions from each individual cross fit the expected.

        3. How you analyze top case on handout 21B:

             a. How you rule out dominance -- because affected person (filled symbol) has normal parents. (Normal kids are consistent with a dominant parent; normal parents are not consistent with a dominant kid.)

             b. How you show this condition could be recessive -- assign a genotype to each individual. Start with the affected person (II-1), who must be aa, then parents (must be Aa), then kids (also Aa). Spouse of affected person is A_ -- could be Aa or AA; if condition is rare, you assume spouse is AA.

           c. Sex Linkage -- is it possible here? Check it out and see! You should be able to see why condition in this pedigree can not be recessive and sex linked. (Could affected mom have normal son?)

        4. Things to note about second case shown on handout 21B.

            a. This pedigree is consistent with dominant inheritance (but see below).  Note that parents of II-1 have the condition being traced but her children do not. This is perfectly consistent with dominant inheritance -- If II-1 is Dd, one of her parents must have had D, but her kids can be dd.

            b. This pedigree is consistent with recessive inheritance if I-1 is a heterozygote (= carrier). It is unlikely that I-1 is a carrier of the same condition affecting his spouse if the condition is rare. 

            c. Could this condition be sex-linked? Try it for yourself. You should be able to see why condition could be dominant & sex-linked but not recessive & sex-linked.

For typical problems involving pedigrees, see 9-11 & 9-15.

Next time: What if you follow the inheritance of more than one gene at a time?

© 2007 Deborah Mowshowitz and Lawrence Chasin Department of Biological Sciences Columbia University New York, NY.